Peter Vadas

7.4k total citations · 1 hit paper
138 papers, 5.7k citations indexed

About

Peter Vadas is a scholar working on Molecular Biology, Immunology and Allergy and Rheumatology. According to data from OpenAlex, Peter Vadas has authored 138 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 40 papers in Immunology and Allergy and 32 papers in Rheumatology. Recurrent topics in Peter Vadas's work include Food Allergy and Anaphylaxis Research (32 papers), Urticaria and Related Conditions (21 papers) and Mast cells and histamine (15 papers). Peter Vadas is often cited by papers focused on Food Allergy and Anaphylaxis Research (32 papers), Urticaria and Related Conditions (21 papers) and Mast cells and histamine (15 papers). Peter Vadas collaborates with scholars based in Canada, United States and United Kingdom. Peter Vadas's co-authors include W. Pruzanski, E. Stefanski, Eva Stefanski, Boris Perelman, John B. Hay, Jeffrey L. Browning, Jeffrey J. Seilhamer, Jeffrey D. Edelson, Jean Kloss and Linda K. Johnson and has published in prestigious journals such as Nature, The Lancet and JAMA.

In The Last Decade

Peter Vadas

132 papers receiving 5.5k citations

Hit Papers

Cloning and Recombinant Expression of Phospholipase A2 Pr... 1989 2026 2001 2013 1989 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cloning and Recombinant Expression of Phospholipase A2 Present in Rheumatoid Arthritic Synovial Fluid
    1989 477 citations W. Pruzanski, Peter Vadas et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Vadas Canada 39 2.2k 1.1k 1.0k 869 825 138 5.7k
Hugh R. Brady Ireland 50 3.0k 1.4× 638 0.6× 2.3k 2.2× 763 0.9× 565 0.7× 125 7.9k
Marek Rola‐Pleszczynski Canada 49 2.0k 0.9× 581 0.5× 2.4k 2.4× 1.8k 2.0× 299 0.4× 232 7.1k
Helen M. Korchak United States 47 2.6k 1.2× 466 0.4× 2.2k 2.2× 1.1k 1.3× 417 0.5× 83 5.8k
Curtis B. Wilson United States 52 2.2k 1.0× 1.1k 1.0× 3.5k 3.5× 831 1.0× 656 0.8× 154 10.2k
Aaron Janoff United States 44 2.0k 0.9× 622 0.6× 1.3k 1.2× 782 0.9× 467 0.6× 128 6.7k
Franco Dallegri Italy 42 1.6k 0.7× 387 0.3× 2.5k 2.5× 714 0.8× 361 0.4× 230 6.5k
Massimo Triggiani Italy 45 1.6k 0.7× 1.4k 1.3× 2.8k 2.8× 1.6k 1.8× 207 0.3× 191 6.6k
Anthony J. Valente United States 55 2.9k 1.3× 804 0.7× 3.2k 3.2× 881 1.0× 325 0.4× 122 8.9k
A. W. Ford‐Hutchinson Canada 33 1.3k 0.6× 633 0.6× 1.4k 1.4× 2.3k 2.6× 418 0.5× 102 5.8k
Henry J. Showell United States 39 2.4k 1.1× 946 0.8× 2.8k 2.7× 999 1.1× 335 0.4× 86 6.1k

Countries citing papers authored by Peter Vadas

Since Specialization
Citations

This map shows the geographic impact of Peter Vadas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Vadas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Vadas more than expected).

Fields of papers citing papers by Peter Vadas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Vadas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Vadas. The network helps show where Peter Vadas may publish in the future.

Co-authorship network of co-authors of Peter Vadas

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Vadas. A scholar is included among the top collaborators of Peter Vadas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Vadas. Peter Vadas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Erika Yue, et al.. (2024). Prevalence of Autoantibodies in Patients with Hereditary Alpha-Tryptasemia. International Archives of Allergy and Immunology. 186(5). 1–7.
2.
Ogbogu, Princess U., C. Bulaï Livideanu, Paul Van Daele, et al.. (2023). AVAPRITINIB IMPROVED GASTROINTESTINAL SYMPTOMS IN PATIENTS WITH INDOLENT SYSTEMIC MASTOCYTOSIS: REGISTRATIONAL DOUBLE-BLIND, PLACEBO-CONTROLLED PIONEER STUDY. Annals of Allergy Asthma & Immunology. 131(5). S81–S81. 1 indexed citations
3.
4.
Lebovic, Gerald, et al.. (2021). Reproducibility of Symptom Sequences Across Episodes of Recurrent Anaphylaxis. The Journal of Allergy and Clinical Immunology In Practice. 10(2). 534–538.e1. 7 indexed citations
5.
Milner, Joshua D., et al.. (2020). Usefulness of testing for hereditary alpha tryptasemia in symptomatic patients with elevated tryptase. The Journal of Allergy and Clinical Immunology In Practice. 8(6). 2066–2067. 12 indexed citations
6.
Vadas, Peter. (2020). Hydrochlorothiazide-induced systemic capillary leak. The American Journal of Emergency Medicine. 38(6). 1299.e1–1299.e2. 5 indexed citations
7.
Trinkaus, Martina, et al.. (2019). Efficacy of Omalizumab in Indolent Systemic Mastocytosis. SHILAP Revista de lepidopterología. 2019. 1–5. 10 indexed citations
8.
Hicks, Lisa K., et al.. (2018). A Retrospective Case Series Describing the Efficacy of Ketotifen in Systemic Mastocytosis. Blood. 132(Supplement 1). 5474–5474. 1 indexed citations
9.
Lee, Erika Yue, et al.. (2018). Characterization of Patients with Ibuprofen Hypersensitivity. International Archives of Allergy and Immunology. 178(2). 177–181. 4 indexed citations
10.
Vadas, Peter & Boris Perelman. (2012). Effect of epinephrine on platelet-activating factor–stimulated human vascular smooth muscle cells. Journal of Allergy and Clinical Immunology. 129(5). 1329–1333. 30 indexed citations
11.
Vadas, Peter, et al.. (2010). Catamenial anaphylaxis in three patients. Acta Medica Academica. 39(1). 71–75.
12.
Arias, Katherine, Derek K. Chu, Tina D. Walker, et al.. (2009). Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions. Journal of Allergy and Clinical Immunology. 124(2). 307–314.e2. 85 indexed citations
13.
Mehra, Saral, et al.. (2002). Insect sting-related deaths in Ontario: 1986–2000 a retrospective review. Journal of Allergy and Clinical Immunology. 109(1). S270–S270. 3 indexed citations
14.
Kennedy, Brian P., Paul Payette, John S. Mudgett, et al.. (1995). A Natural Disruption of the Secretory Group II Phospholipase A2 Gene in Inbred Mouse Strains. Journal of Biological Chemistry. 270(38). 22378–22385. 295 indexed citations
15.
Ellies, Lesley G., Johan N.M. Heersche, W. Pruzanski, Peter Vadas, & Jane E. Aubin. (1993). The Role of Phospholipase A2 in Interleukin-1α-mediated Inhibition of Mineralization of the Osteoid Formed by Fetal Rat Calvaria Cells in vitro. Journal of Dental Research. 72(1). 18–24. 11 indexed citations
16.
Pruzanski, W., et al.. (1992). Inhibition of enzymatic activity of phospholipases A2 by minocycline and doxycycline. Biochemical Pharmacology. 44(6). 1165–1170. 99 indexed citations
17.
Vadas, Peter, Kieran F. Scott, G. L. Smith, et al.. (1992). Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock. Life Sciences. 50(11). 807–811. 54 indexed citations
18.
Pruzanski, W., et al.. (1990). Hypophospholipasemia A2 in systemic sclerosis.. PubMed. 17(9). 1182–6. 1 indexed citations
19.
Vadas, Peter. (1984). Elevated plasma phospholipase A2 levels: correlation with the hemodynamic and pulmonary changes in gram-negative septic shock.. PubMed. 104(6). 873–81. 163 indexed citations
20.
Vadas, Peter & John B. Hay. (1982). The appearance and significance of phospholipase A2 in lymph draining tuberculin reactions.. PubMed. 107(3). 285–91. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hugh R. Brady Breakdown of academic impact, for papers by Marek Rola‐Pleszczynski Breakdown of academic impact, for papers by Helen M. Korchak Breakdown of academic impact, for papers by Curtis B. Wilson Breakdown of academic impact, for papers by Aaron Janoff Breakdown of academic impact, for papers by Franco Dallegri Breakdown of academic impact, for papers by Massimo Triggiani Breakdown of academic impact, for papers by Anthony J. Valente Breakdown of academic impact, for papers by A. W. Ford‐Hutchinson Breakdown of academic impact, for papers by Henry J. Showell
Rankless by CCL
2026